Skip to main content
. 2024 Jun 20;13:100111. doi: 10.1016/j.ijpt.2024.100111

Table 2.

Provider-reported toxicity—proton.

Group
Covariate Statistics Level Proton+RS
N = 50
Proton-RS
N = 26
P-valuea
A-GU N (Col %) 0 6 (12.24) 1 (3.85) .59
N (Col %) 1 10 (20.41) 6 (23.08)
N (Col %) 2+ 33 (67.35) 19 (73.08)
A-GI N (Col %) 0 46 (93.88) 18 (69.23) .01
N (Col %) 1 3 (6.12) 6 (23.08)
N (Col %) 2+ 0 (0) 2 (7.69)
L-GU N (Col %) 0 22 (46.81) 6 (26.09) .15
N (Col %) 1 4 (8.51) 1 (4.35)
N (Col %) 2+ 21 (44.68) 16 (69.57)
L-GI N (Col %) 0 43 (91.49) 17 (73.91) .08
N (Col %) 1 4 (8.51) 5 (21.74)
N (Col %) 2+ 0 (0) 1 (4.35)
R-GU N (Col %) 0 25 (53.19) 6 (26.09) .08
N (Col %) 1 2 (4.26) 1 (4.35)
N (Col %) 2+ 20 (42.55) 16 (69.57)
R-GI N (Col %) 0 45 (95.74) 17 (73.91) .01
N (Col %) 1 2 (4.26) 5 (21.74)
N (Col %) 2+ 0 (0) 1 (4.35)

Notes: Univariable analysis of CTCAE v5.0 toxicity at specified time points in proton-treated patients.

Abbreviations: Proton+RS, proton with rectal spacer; Proton-RS, proton without rectal spacer; and A/L/R GU and GI, acute (<3 months), max late (≥3 months), most recent (≥3 months) genitourinary and gastrointestinal toxicities, respectively. P values <0.05 included in bold.

a

The P-value is calculated by χ2 test or Fisher exact, where appropriate.